체외막 산소 공급 시스템 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 모달리티별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Extra Corporeal Membrane Oxygenation System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Modality, By Application, By End-User, By Region and Competition, 2020-2030F
세계의 체외막 산소 공급(ECMO) 시스템 시장은 2024년에 5억 7,120만 달러로 평가되며, 예측 기간에는 7억 8,248만 달러에 달할 것으로 예측되며, 2030년까지 CAGR은 5.36%입니다.
체외막 산소 공급(ECMO) 시스템 시장은 중환자실 환경에서 첨단 생명유지 기술에 대한 수요가 증가함에 따라 크게 성장하고 있으며, ECMO 시스템은 장시간 체외 순환과 산소 공급을 통해 중증 심부전 및 호흡부전 환자 관리에 중요한 역할을 하고 있습니다. 중요한 역할을 합니다. 생존율 향상에 대한 ECMO의 효과에 대한 의료 전문가들의 인식이 높아짐에 따라 ECMO의 보급에 기여하고 있습니다. 실시간 모니터링, 컴팩트한 디자인, 자동화와 같은 혁신적인 기능의 통합으로 시스템의 성능과 사용 편의성이 더욱 향상되고 있습니다. 심혈관 질환, 호흡기 질환, 장기 부전, 특히 중환자실(ICU)과 심장 전문센터에서의 ECMO의 필요성이 증가하고 있습니다. 의료 기술의 발전은 환자의 예후를 개선하여 ECMO를 생명을 위협하는 병태생리에 대한 바람직한 개입으로 만들고 있습니다.
| 시장 개요 |
| 예측 기간 |
2026-2030년 |
| 시장 규모 : 2024년 |
5억 7,120만 달러 |
| 시장 규모 : 2030년 |
7억 8,248만 달러 |
| CAGR : 2025-2030년 |
5.36% |
| 급성장 부문 |
병원·클리닉 |
| 최대 시장 |
북미 |
ECMO 기술의 발전으로 휴대가 간편하고 사용하기 쉬운 시스템의 개발이 진행되고 있습니다. 연구개발에 대한 투자 증가로 효율성이 향상되고, 합병증이 감소하며, 환자의 안전성이 개선된 장비가 개발되고 있습니다. 저침습적 경피적 ECMO 캐뉼레이션 기술이 선호되면서 시술의 위험이 감소하고, 기존 병원 환경 외에 ECMO의 적용 범위가 넓어지고 있습니다. 심장 및 폐 이식 수술 증가는 수술 전후 지원을 위해 ECMO의 사용을 필요로 하며, 시장 성장을 더욱 촉진하고 있습니다. 인공지능(AI)과 데이터 분석의 통합은 임상의가 ECMO의 성능을 모니터링하고 최적화하여 환자 관리를 개선하는 데 도움이 되고 있습니다. 선진국의 우호적인 상환 정책은 에크모 치료에 대한 환자의 접근성을 향상시키고 있으며, 신생아 및 소아 의료에 대한 관심이 높아지면서 대상 환자가 확대되고 있습니다. 의료 서비스 프로바이더와 의료기기 제조업체의 협력은 특히 중환자 의료 인프라가 빠르게 발전하고 있는 신흥 시장에서 에크모 시스템의 채택을 가속화하고 있습니다.
주요 시장 성장 촉진요인
의료 기술의 진보
주요 시장이 해결해야 할 과제
고비용과 자원 집약도
주요 시장 동향
기술의 진보와 소형화
목차
제1장 제품 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 체외막 산소 공급(ECMO) 시스템 시장 전망
- 시장 규모·예측
- 시장 점유율·예측
- 모달리티별(동맥-정맥(VA), 정맥-정맥(VV), 기타)
- 용도별(호흡기 용도, 심장 용도, 체외 심폐 소생(ECPR))
- 최종사용자별(병원·진료소, 외래 진료 센터, 기타)
- 지역별
- 기업별(2024년)
- 시장 맵
제6장 북미의 체외막 산소 공급(ECMO) 시스템 시장 전망
- 시장 규모·예측
- 시장 점유율·예측
- 북미 : 국가별 분석
제7장 유럽의 체외막 산소 공급(ECMO) 시스템 시장 전망
- 시장 규모·예측
- 시장 점유율·예측
- 유럽 : 국가별 분석
제8장 아시아태평양의 체외막 산소 공급(ECMO) 시스템 시장 전망
- 시장 규모·예측
- 시장 점유율·예측
- 아시아태평양 : 국가별 분석
제9장 남미의 체외막 산소 공급(ECMO) 시스템 시장 전망
- 시장 규모·예측
- 시장 점유율·예측
- 남미 : 국가별 분석
제10장 중동 및 아프리카의 체외막 산소 공급(ECMO) 시스템 시장 전망
- 시장 규모·예측
- 시장 점유율·예측
- 중동 및 아프리카 : 국가별 분석
제11장 시장 역학
제12장 시장 동향과 발전
제13장 세계의 체외막 산소 공급(ECMO) 시스템 시장 : SWOT 분석
제14장 경쟁 구도
- LivaNova(Alung Technologies Inc.)
- Eurosets
- Getinge AB
- Medtronic PLC
- Microport Scientific Corporation
- Nipro Medical Corporation
- Terumo Medical Corporation
- Abbott Laboratories
- Fresenius Medical Care Company
제15장 전략적 제안
제16장 조사회사 소개·면책사항
KSA
Global Extra Corporeal Membrane Oxygenation (ECMO) System Market was valued at USD 571.20 Million in 2024 and is expected to reach USD 782.48 Million in the forecast period with a CAGR of 5.36% through 2030. The Extracorporeal Membrane Oxygenation (ECMO) System Market is experiencing significant expansion due to the growing demand for advanced life-support technologies in critical care settings. ECMO systems play a crucial role in managing patients with severe cardiac and respiratory failure by providing prolonged extracorporeal circulation and oxygenation. Increased awareness among healthcare professionals regarding the effectiveness of ECMO in improving survival rates has contributed to its widespread adoption. The integration of innovative features such as real-time monitoring, compact designs, and automation is further enhancing system performance and usability. Rising cases of cardiovascular diseases, respiratory disorders, and organ failure are driving the need for ECMO, particularly in intensive care units (ICUs) and specialized cardiac centers. Advancements in medical technologies are also improving patient outcomes, making ECMO a preferred intervention in life-threatening conditions.
| Market Overview |
|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 571.20 Million |
| Market Size 2030 | USD 782.48 Million |
| CAGR 2025-2030 | 5.36% |
| Fastest Growing Segment | Hospitals & Clinics |
| Largest Market | North America |
Advancements in ECMO technology are reshaping the market, leading to the development of portable and user-friendly systems. Increasing investments in research and development have resulted in devices with enhanced efficiency, reduced complications, and improved patient safety. The growing preference for minimally invasive and percutaneous ECMO cannulation techniques has reduced procedural risks and expanded the applicability of ECMO beyond traditional hospital settings. An increasing number of heart and lung transplant procedures also necessitate the use of ECMO for perioperative support, further driving market growth. The integration of artificial intelligence (AI) and data analytics is helping clinicians monitor and optimize ECMO performance, leading to better patient management. Favorable reimbursement policies in developed countries are enhancing patient access to ECMO therapy, while the growing focus on neonatal and pediatric care is expanding the target patient population. Collaborations between healthcare providers and medical device manufacturers are accelerating the adoption of ECMO systems, particularly in emerging markets where critical care infrastructure is rapidly developing.
Key Market Drivers
Advancements in Medical Technology
Advancements in medical technology have significantly enhanced extracorporeal membrane oxygenation (ECMO) systems, improving their efficacy, safety, and overall utility. These innovations are particularly crucial given the rising prevalence of cardiovascular diseases (CVDs) and respiratory failures, which are leading causes of mortality globally.
In the United States, heart disease remains the leading cause of death, accounting for 702,880 fatalities in 2022, which represents 1 in every 5 deaths. Coronary heart disease (CHD) is the most common type, responsible for 371,506 deaths in the same year. Additionally, about 1 in 20 adults aged 20 and older have CHD. Each year, approximately 805,000 Americans experience a heart attack, with 605,000 being first occurrences and 200,000 happening in individuals who have already had a heart attack.
Key Market Challenges
High Costs and Resource Intensity
ECMO therapy is a highly specialized and resource-intensive medical intervention. The equipment itself is expensive, and the overall cost of ECMO treatment includes not only the machine but also the required disposables, personnel, and infrastructure. Running an ECMO program demands a skilled team of healthcare professionals, including perfusionists and specially trained nurses, as well as dedicated facilities with the necessary technology and expertise.
Financial Burden: The high upfront costs associated with establishing and maintaining an ECMO program can be a substantial financial burden for healthcare institutions, particularly smaller hospitals and clinics. Due to the resource-intensive nature of ECMO, it may not be readily available in all healthcare settings, limiting access for patients in remote areas or regions with fewer healthcare resources. The cost barrier can exacerbate healthcare disparities, as not all patients may have equal access to ECMO treatment, potentially leading to unequal outcomes based on socioeconomic factors.
Key Market Trends
Technological Advancements and Miniaturization
One prominent trend in the global ECMO System Market is the continuous advancement of technology and the development of more compact, portable ECMO systems. This trend aims to make ECMO therapy more accessible and versatile.
Miniaturized ECMO Machines: Manufacturers are working on creating smaller, more portable ECMO machines that are easier to transport and set up. This makes ECMO treatment feasible in a wider range of healthcare settings, including ambulances and remote clinics. ECMO systems are increasingly being integrated with advanced monitoring devices and artificial intelligence algorithms. This integration allows for real-time monitoring of patient vitals, helping healthcare providers make informed decisions and detect complications earlier. Some ECMO systems now offer wireless connectivity, enabling healthcare teams to monitor patients remotely. This feature is especially valuable for critical care patients who require continuous monitoring even during inter-hospital transfers.
Key Market Players
- LivaNova (Alung Technologies Inc.)
- Eurosets
- Getinge AB
- Medtronic PLC
- Microport Scientific Corporation
- Nipro Medical Corporation
- Terumo Medical Corporation
- Abbott Laboratories
- Fresenius Medical Care Company
Report Scope:
In this report, the Global Extra Corporeal Membrane Oxygenation (ECMO) System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Extra Corporeal Membrane Oxygenation (ECMO) System Market, By Modality:
- Veno-Arterial (VA)
- Veno-Venous (VV)
- Others
Extra Corporeal Membrane Oxygenation (ECMO) System Market, By Application:
- Respiratory Applications
- Cardiac Applications
- Extracorporeal Cardiopulmonary Resuscitation (ECPR)
Extra Corporeal Membrane Oxygenation (ECMO) System Market, By End-User:
- Hospitals & Clinics
- Ambulatory Care Centers
- Others
Extra Corporeal Membrane Oxygenation (ECMO) System Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Extra Corporeal Membrane Oxygenation (ECMO) System Market.
Available Customizations:
Global Extra Corporeal Membrane Oxygenation (ECMO) System market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 5.1. Market Size & Forecast
- 5.2. Market Share & Forecast
- 5.2.1. By Modality (Veno-Arterial (VA), Veno-Venous (VV), Others)
- 5.2.2. By Application (Respiratory Applications, Cardiac Applications, Extracorporeal Cardiopulmonary Resuscitation (ECPR))
- 5.2.3. By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
- 5.3. Market Map
6. North America Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 6.1. Market Size & Forecast
- 6.2. Market Share & Forecast
- 6.2.1. By Modality
- 6.2.2. By Application
- 6.2.3. By End-User
- 6.2.4. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Modality
- 6.3.1.2.2. By Application
- 6.3.1.2.3. By End-User
- 6.3.2. Canada Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Modality
- 6.3.2.2.2. By Application
- 6.3.2.2.3. By End-User
- 6.3.3. Mexico Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Modality
- 6.3.3.2.2. By Application
- 6.3.3.2.3. By End-User
7. Europe Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 7.1. Market Size & Forecast
- 7.2. Market Share & Forecast
- 7.2.1. By Modality
- 7.2.2. By Application
- 7.2.3. By End-User
- 7.3. Europe: Country Analysis
- 7.3.1. Germany Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Modality
- 7.3.1.2.2. By Application
- 7.3.1.2.3. By End-User
- 7.3.2. United Kingdom Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Modality
- 7.3.2.2.2. By Application
- 7.3.2.2.3. By End-User
- 7.3.3. Italy Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.2. Market Share & Forecasty
- 7.3.3.2.1. By Modality
- 7.3.3.2.2. By Application
- 7.3.3.2.3. By End-User
- 7.3.4. France Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Modality
- 7.3.4.2.2. By Application
- 7.3.4.2.3. By End-User
- 7.3.5. Spain Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Modality
- 7.3.5.2.2. By Application
- 7.3.5.2.3. By End-User
8. Asia-Pacific Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 8.1. Market Size & Forecast
- 8.2. Market Share & Forecast
- 8.2.1. By Modality
- 8.2.2. By Application
- 8.2.3. By End-User
- 8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Modality
- 8.3.1.2.2. By Application
- 8.3.1.2.3. By End-User
- 8.3.2. India Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Modality
- 8.3.2.2.2. By Application
- 8.3.2.2.3. By End-User
- 8.3.3. Japan Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Modality
- 8.3.3.2.2. By Application
- 8.3.3.2.3. By End-User
- 8.3.4. South Korea Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Modality
- 8.3.4.2.2. By Application
- 8.3.4.2.3. By End-User
- 8.3.5. Australia Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Modality
- 8.3.5.2.2. By Application
- 8.3.5.2.3. By End-User
9. South America Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 9.1. Market Size & Forecast
- 9.2. Market Share & Forecast
- 9.2.1. By Modality
- 9.2.2. By Application
- 9.2.3. By End-User
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Modality
- 9.3.1.2.2. By Application
- 9.3.1.2.3. By End-User
- 9.3.2. Argentina Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Modality
- 9.3.2.2.2. By Application
- 9.3.2.2.3. By End-User
- 9.3.3. Colombia Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Modality
- 9.3.3.2.2. By Application
- 9.3.3.2.3. By End-User
10. Middle East and Africa Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 10.1. Market Size & Forecast
- 10.2. Market Share & Forecast
- 10.2.1. By Modality
- 10.2.2. By Application
- 10.2.3. By End-User
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Modality
- 10.3.1.2.2. By Application
- 10.3.1.2.3. By End-User
- 10.3.2. Saudi Arabia Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Modality
- 10.3.2.2.2. By Application
- 10.3.2.2.3. By End-User
- 10.3.3. UAE Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Modality
- 10.3.3.2.2. By Application
- 10.3.3.2.3. By End-User
11. Market Dynamics
- 11.1. Drivers & Challenges
12. Market Trends & Developments
- 12.1. Recent Developments
- 12.2. Product Launches
- 12.3. Mergers & Acquisitions
13. Global Extra Corporeal Membrane Oxygenation (ECMO) System Market: SWOT Analysis
14. Competitive Landscape
- 14.5.1. LivaNova (Alung Technologies Inc.)
- 14.5.2. Eurosets
- 14.5.3. Getinge AB
- 14.5.4. Medtronic PLC
- 14.5.5. Microport Scientific Corporation
- 14.5.6. Nipro Medical Corporation
- 14.5.7. Terumo Medical Corporation
- 14.5.8. Abbott Laboratories
- 14.5.9. Fresenius Medical Care Company
15. Strategic Recommendations
16. About Us & Disclaimer
